Lawrence P. (Larry) Wennogle, Ph.D.

Larry Wennogle, Ph.D. has extensive work experience in the field of pharmaceutical research. Lawrence P. (Larry) is currently the Vice President of Translational Research at Psylo, a company focused on developing medications for central nervous system diseases. Prior to joining Psylo, they founded their own company, Lawrence P. Wennogle, PhD & Associates, in 2019. From 2003 to 2019, they served as the Vice President of Drug Discovery at Intra-Cellular Therapies, Inc. Additionally, Larry has worked as an Adjunct Professor at Rutgers University from 2002 to 2013. Lawrence P. (Larry) has also held senior research positions at Novartis and Ciba-Geigy Pharmaceuticals, contributing to scientific advancements in the field.

Lawrence P. (Larry) Wennogle, Ph.D. pursued their education in a chronological order as follows:

From 1971 to 1978, Larry attended the University of Colorado Boulder, where they obtained their Ph.D. degree in Biochemistry and Molecular Biology.

Prior to that, Larry's education history mentions that they completed a BA degree in Chemistry from Ithaca College. However, specific years are not provided.

Following their Ph.D., Larry went on to continue their research at the Pasteur Institute in Paris, France as a Muscular Dystrophy Association Post-Doctoral Fellow. This research focused on Molecular Neurosciences. Again, no specific years are mentioned.

Before their higher education, Larry attended Summit High School. Additional details regarding the years and any degrees earned from this institution are not provided.

Lastly, it is noted that Larry pursued further studies at the University of Colorado Boulder, where they obtained another Ph.D. degree, this time in Chemistry/Biochemistry. However, the exact timeframe for this educational achievement is not specified.